Brain proton magnetic spectroscopy in long-term treatment of Wilson’s disease patients

被引:0
|
作者
Beata Tarnacka
Wojciech Szeszkowski
Marek Gołębiowski
Anna Członkowska
机构
[1] Institute of Psychiatry and Neurology,2nd Neurological Department
[2] Warsaw Medical University,II Department of Clinical Radiology
[3] Warsaw Medical University,I Department of Clinical Radiology
[4] Medical Academy,Department of Clinical and Experimental Pharmacology
来源
Metabolic Brain Disease | 2010年 / 25卷
关键词
Wilson disease; Magnetic resonance spectroscopy; Treatment;
D O I
暂无
中图分类号
学科分类号
摘要
We reported the brain proton magnetic resonance spectroscopy (MRS) findings in 27 Wilson’s disease (WD) patients treated more than 6 years in neurological (nWD) and hepatic (hWD) subgroups. We investigated 4 hWD patients, with no improvement and 8 with marked improvement; and 8 nWD patients with marked improvement and 7 with no improvement of clinical status. In nWD patients with improvement the MRS showed significantly higher Cho/Cr, Glx/Cr ratios levels. In hWD patients with no improvement the lower Cho/Cr and in nWD significantly lower NAA/Cr and higher Cho/Cr and Lip/Cr ratios were detected. In nWD patients with improvement the spectroscopic pattern, can be related to gliosis. In patients with no neurological improvement a persistent neuronal dysfunction can occur, perhaps as a result of copper or iron deposition.
引用
收藏
页码:375 / 379
页数:4
相关论文
共 50 条
  • [31] Mildly Impaired Foot Control in Long-Term Treated Patients with Wilson's Disease
    Samadzadeh, Sara
    Hefter, Harald
    Tezayak, Osman
    Rosenthal, Dietmar
    JOURNAL OF FUNCTIONAL MORPHOLOGY AND KINESIOLOGY, 2022, 7 (01)
  • [32] Long-term tacrine treatment in patients with Alzheimer's disease
    Solomon, PR
    Knapp, MJ
    Gracon, SI
    Groccia, M
    Pendlebury, WW
    LANCET, 1996, 348 (9022): : 275 - 276
  • [33] Long-term donepezil treatment in patients with Alzheimer’s disease
    Andrew Kertesz
    Current Neurology and Neuroscience Reports, 2004, 4 (6) : 459 - 460
  • [34] Brain magnetic resonance imaging in patients with Wilson's disease
    Kozic, D
    Svetel, M
    Semnic, R
    Petrovic, I
    Dragasevic, N
    Kostic, VS
    MOVEMENT DISORDERS, 2002, 17 : S230 - S230
  • [35] Wilson's Disease: Brain MR Imaging and Proton-MR Spectroscopy Findings
    Aydin, Hasan
    Damar, Cagri
    Kizilgoz, Volkan
    Hekimoglu, Baki
    ERCIYES MEDICAL JOURNAL, 2012, 34 (04) : 197 - 200
  • [36] MR Spectroscopy in monitoring the treatment of Wilson's disease patients
    Tarnacka, Beata
    Szeszkowski, Wojciech
    Golebiowski, Marek
    Czlonkowska, Anna
    MOVEMENT DISORDERS, 2008, 23 (11) : 1560 - 1566
  • [37] Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate
    Czlonkowska, A
    Gajda, J
    Rodo, M
    JOURNAL OF NEUROLOGY, 1996, 243 (03) : 269 - 273
  • [38] TETRAETHYLENTETRAMIN AS FIRST LINE TREATMENT OF WILSON DISEASE - LONG-TERM RESULTS
    Ferenci, Peter
    Mohr, Isabelle, Jr.
    Staettermayer, Albert
    Stauber, Rudolf E.
    Panzer, Marlene
    Steindl-Munda, Petra E.
    Merle, Uta
    Trauner, Michael H.
    Weiss, Karl Heinz
    HEPATOLOGY, 2022, 76 : S1121 - S1122
  • [39] Treatment of Wilson's disease with zinc: XV - Long-term follow-up studies
    Brewer, GJ
    Dick, RD
    Johnson, VD
    Brunberg, JA
    Kluin, KJ
    Fink, JK
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1998, 132 (04): : 264 - 278
  • [40] Heterozygous carriers for Wilson's disease-magnetic spectroscopy changes in the brain
    Tarnacka, Beata
    Szeszkowski, Wojciech
    Buettner, Janine
    Golebiowski, Marek
    Gromadzka, Grazyna
    Czlonkowska, Anna
    METABOLIC BRAIN DISEASE, 2009, 24 (03) : 463 - 468